To discover and characterize b cell epitopes against the viral pathogens rvfv, cchfv, and EV-D68.
Active Definitive Contract Awarded Last action
- Contract number
- 75N93024C00071
- Awardee
-
Integral Molecular Inc. UEI DY9KSWE8EJB8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,866,955
Award facts
- Opportunity
-
- Innovations in functional b cell epitope discovery Pre-Solicitation · BAANIAID75N93023R00002 · Posted May 5, 2023
- Contract value 60% obligated
-
- $4,866,955.00 Current, with exercised options
- $8,077,093.00 Potential, with all options
- Completion date 42% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 18 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Philadelphia, PA 19104, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $1,575,147 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,722,325 | |
| Original award | $1,569,483 |
About this award
The National Institute of Allergy and Infectious Diseases awarded an $8.077 million cost-plus-fixed-fee definitive contract to Integral Molecular Inc. to discover and characterize B cell epitopes against the viral pathogens RVFV, CCHFV, and EV-D68, with innovations in functional B cell epitope discovery, on September 16, 2024.
Performance takes place in Philadelphia, PA. The originating pre-solicitation was posted May 5, 2023 with a due date of May 22, 2023. The contract extends through September 15, 2029.
In FY2025, Integral Molecular invoiced $1.2 million across 6.4 FTEs and 13,298 contractor hours, yielding a derived government-paid rate of $87.73 per hour. The company reported one subcontractor, accounting for eight percent of contractor hours.
Quick answers
Who was awarded contract 75N93024C00071?
75N93024C00071 was awarded to Integral Molecular Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 16, 2024.
How much is contract 75N93024C00071 worth?
The government has obligated $4,866,955 on 75N93024C00071. Its potential value, with all options, is $8,077,093.
Was contract 75N93024C00071 competed?
The extent of competition for 75N93024C00071 was full and open competition. The government received 18 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award